Repeated corticosteroid injections around the Greater Occipital Nerve (GON) as prophylactic treatment in chronic cluster headache - REGON / Repeated GON injections in CCH

eiden University Medical Centre0 个研究点目标入组 50 人开始时间: 2022年4月12日最近更新: 2024年3月4日

适应症

试验速览

暂无简介。

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•- Age =18
•- Chronic cluster headache (International Classification of Headache Disorders – third edition; ICHD-3)
•- Ictal pain must be always at the same side
•- =8 weekly attacks of cluster headache in the prospective one-month baseline observation period
•- On a stable regimen of cluster headache prophylactics for >4 weeks prior to onset of study treatment and agreeing not to increase the dose and not starting a new cluster prophylactic during the study period
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 45
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 5

•A potential subject who meets any of the following criteria will be excluded from participation in this study:
•- Contra-indication against, or current use of, corticosteroids
•- Occipital nerve stimulation (ONS)
•- Use of anticoagulation medication or a known bleeding disorder
•- Inability to use an electronic diary to monitor individual attacks and other items
•- Other headaches if the patient cannot reliably distinguish them from attacks of cluster headache
•- Current use of prophylactic medication for other headaches
•- Pregnancy

发起方

eiden University Medical Centre